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Exacerbations of chronic obstructive pulmonary
disease
An analysis of the care process in a regional hospital emergency
department
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Abstract
To describe the characteristics of patients visiting a Hospital Emergency Department (HED) due to chronic obstructive pulmonary
disease (COPD) exacerbation (AECOPD) and to evaluate their management.
A cross-sectional study of the ﬁrst 219 patients with AECOPD visiting the HED of the University Hospital Arnau de Vilanova, Lleida,
Spain, was performed from January to May 2016. The data collected included the following: main patient characteristics, diagnostic
tests, applied treatments, response times, discharge destination, need for hospital admission, and re-admissions and deaths at 90
days. Comparisons were made according to sex and need for hospitalization.
The patients consisted of 84%men, with amean age (standard deviation [SD]) of 75.9 (11) years and a FEV1/FVC of 56 (13)%; 63%
were ex-smokers. The median time (P25–P75) in the HED was 6 (4–10)hours, with shorter waiting times for severe patients.
Additionally, 74% of patients required hospital admission. The percentages of re-admissions and mortality at 90 days were 25% and
14%, respectively. Among female patients, 63% never consumed tobacco, and the most frequent clinical phenotype was asthma
combined with COPD; female patients visited the family doctor sooner after AECOPD than men (4 vs 7 days). Overall, the following
areas of improvement were identiﬁed: use of sputum culture (performed in 3% of patients); documentation of variables; patient care
times; and reduction in the time until ﬁrst medical check-up.
The overall quality of care provided to AECOPD patients was satisfactory and consistent with current clinical guidelines.
Nevertheless, improving the quality of care at the HED requires establishing protocols that ensure that the necessary diagnostic tests
are performed, optimize response times and guarantee that all relevant information is collected.
Abbreviations: AECOPD = chronic obstructive pulmonary disease exacerbation, COPD = chronic obstructive pulmonary
disease, ECAP = primary care electronic medical record, GOLD = global initiative for chronic obstructive lung disease, HED =
Hospital Emergency Department, HH = home hospitalization, mMRC =Modiﬁed Medical Research Council, PC = primary care, SD
= standard deviation.
Keywords: care management, chronic obstructive pulmonary disease, chronic obstructive pulmonary disease exacerbation,
emergencies
1. Introduction
Chronic obstructive pulmonary disease (COPD) is a progressive
and debilitating respiratory condition that leads to signiﬁcant
burden in terms of hospital resources, generating more than
50,000 admissions per year with an average stay of 8.25 days.[1]
In Spain, COPD accounts for 10% of all hospital admissions and
2% of all visits to hospital emergency departments (HEDs).[2]
However, the quality of care provided in HEDs for COPD
exacerbations (AECOPD) is not homogeneous, and usual
practice is not always systematic or consistent with the
recommendations of the clinical guidelines.[3]
The need for hospital admissions has been of increasing
concern. In fact, a study conducted in a Spanish third-level
hospital estimated that the rate of unjustiﬁed hospital admissions
exceeded 17%, mainly due to organizational factors related to
the care process.[4]
Different factors inﬂuencing the admission andmanagement of
COPD patients have been studied,[5] and tools such as the
ADIEPOC,[6] that allows for assessment of whether an admission
from the HED is needed, have been developed. Similarly, the
efﬁcient use of alternative routes to conventional hospitalization,
such as home hospitalization programs (HH), has demonstrated
a signiﬁcant impact on hospital dynamics (bed availability) and
costs associated with AECOPD while maintaining high patient
care and satisfaction standards.[7] Finally, in the area of
prevention of new AECOPD, coordination between the different
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areas of care (emergency department, primary care [PC], and
specialized hospital care) has proven to be fundamental.[8] The
recommendations of national and international guidelines
indicate that the ﬁrst contact with PC should occur within the
ﬁrst 30 days after discharge after AECOPD.[9,10]
Therefore, a precise characterization of the actual health care
situation in each HED would allow for the identiﬁcation of
speciﬁc aspects to be improved and is thus necessary to achieve
substantial improvements in the care provided to AECOPD
patients. These improvements are especially important in HEDs
located in low population density regions, which are usually
under-studied and experience additional organizational difﬁcul-
ties arising from the large geographic area that needs to be
covered. An example of such centers is the University Hospital
Arnau de Vilanova de Lleida, Spain, the only referral hospital for
>450,000 patients in an extensive territorial area (both urban
and rural). Therefore, our objective was to identify the
characteristics of the patients visiting the HED due to AECOPD
and to evaluate the current management at the health care level,
the necessity of hospital admission, and the use of HH and other
alternatives to conventional hospitalization, all within the
framework of a study to improve AECOPD care.
2. Methods
2.1. Study design and participants
A descriptive cross-sectional study of patients with a diagnosis of
AECOPD treated at the University Hospital Arnau de Vilanova
de Lleida, Spain, was performed between January 1st and May
31st, 2016. At the time of data collection, all the patients had
either a spirometric conﬁrmation of COPD according to the
international guidelines or a COPD diagnosis with speciﬁc
follow-up for COPD in PC or Respiratory department. In the
latter case, inclusion required corroboration of the case by the
research team based on the information available in the electronic
clinical records of the hospital or PC. The exclusion criteria were:
presence of any identiﬁable causes of worsening of symptoms
(pneumonia, pneumothorax, decompensated or unrecognized
arrhythmia, ischemic heart disease, pulmonary thromboembo-
lism, and left heart failure); need for invasive mechanical
ventilation (orotracheal intubation) at the time of ﬁrst medical
care (as patients requiring invasive mechanical ventilation upon
arrival at the ED are transferred to the Intensive Care Unit and
thus not managed in the ED); or monitoring and control by home
care programs or palliative care units.
2.2. Measures
Based on the data available in the electronic medical records of
each patient, the following variables were collected: sociodemo-
graphic and lifestyle data (age, sex, smoking, and alcohol
consumption); comorbidities (age-modiﬁed Charlson index);
baseline characteristics of COPD (degree of obstruction, basal
dyspnea, history of exacerbations during the last 12 months,
Global Initiative for Chronic Obstructive Lung Disease [GOLD]
2017 ABCD classiﬁcation and usual treatment); and AECOPD-
related variables (date of onset of symptoms, Anthonisen criteria,
previous treatment received, vital signs, pulse oximetry oxygen
saturation, inspired oxygen fraction, complementary tests, and
pharmacological treatment). The following data were extracted
from the Registry of Management of the HED: waiting times;
triage category; and destination at discharge. The necessity of
hospital admission was evaluated using the ADIEPOC tool used
in the Research on Results and Health Services (IRYSS) COPD
project[6];this tool takes into account variables such as the partial
pressure of oxygen and carbon dioxide in the arterial blood
(PaO2 and PaCO2, respectively), degree of dyspnea, and level of
consciousness. Finally, the following data were obtained from the
information available in the primary care electronic medical
record (ECAP): time to ﬁrst PC assessment after AECOPD;
number of readmissions at 30 and 90 days; and mortality at 30
and 90 days.
All data were collected by medical research personnel and
entered into an anonymized database. The study was approved
by the ethics committee of the University Hospital Arnau de
Vilanova de Lleida (approval number: 10/2015).
2.3. Statistical analysis
Means (standard deviation [SD]) or medians (P25–P75) were used
for continuous variables, whereas categorical variables were
reported as the absolute number and percentage. Comparisons
were performed between subjects who did and did not require
hospitalization after care in theHED. The statistical signiﬁcance of
comparisons was assessed by Chi square test, Student t test, or
Mann–Whitney U test, according to the characteristics of each
variable. Additionally, stratiﬁed analyses according to sex were
performed. All contrasts were bilateral, and a value of P< .05 was
considered statistically signiﬁcant. All analyses were performed
using Stata 12.1 software (StataCorp, College Station, TX).
3. Results
Between January 1st and May 31st, 2016, 250 patients were
treated in the studied HED with a diagnosis of AECOPD. Thirty-
one patients were excluded (10 for having spirometry measures
not compatible with the diagnosis of COPD and 21 because of the
presence of a non-COPD predominant respiratory disease). The
ﬁnal sample consisted of 219 patients, 84% of whom were men,
themean age (SD) was 76 (11) years, and the mean (SD) Charlson
index was 6.6 (2.1). In the ﬁnal sample, 81% of patients had mild
to moderate obstruction and 19% had severe to very severe
obstruction. The mean (SD) number of exacerbations in the year
prior to admission was 2.1 (1.7) for mild to moderate
exacerbations and 0.9 (1.3) for severe exacerbations. One
hundred sixty-one patients (74%) were hospitalized, and only
1% were in HH programs. According to the ADIEPOC tool, no
unnecessary hospital admissions occurred, with 4% of admis-
sions classiﬁed as doubtful and 96% as justiﬁed. The median time
(P25–P75) in the HED was 6 (4–10)hours. Sputum culture was
requested in only 3% of cases, and an electrocardiogram was
performed in 50% of the cases.
Table 1 shows the main characteristics of AECOPD patients
treated in the HED, the variables speciﬁc to AECOPD, treatment
variables and caremanagement depending onwhether the patient
required hospitalization. No signiﬁcant differences were ob-
served between the 2 groups regarding the rate of re-consultation
at the HED, re-hospitalization, and mortality at 30 and 90 days.
Age, FEV1/FVC ratio, number of admissions in the previous year,
and hypoxemia constituted the main differences between the
patients who did and did not require hospitalization. Table 1 also
shows the number of patients with complete data for each
variable. It should be noted that although the registry was close to
100% for most variables, variables such as respiratory rate were
recorded in only 50% of patients.
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Table 1
Description of the main characteristics and care data of patients with COPD exacerbation depending on admission to the hospital.
n
∗
All (n=219) No admission (n=58) Admission (n=161) P-value†
Sociodemographic variables
Age, y 219 75.9 (11.1) 72.5 (11.4) 77.1 (10.8) .007
Sex 219 .910
Men 184 (84%) 49 (84%) 135 (84%)
Women 35 (16%) 9 (16%) 26 (16%)
Comorbidity and lifestyle
Tobacco 218 .227
Never 39 (18%) 11 (19%) 28 (18%)
Current smoker 41 (19%) 15 (26%) 26 (16%)
Ex-smoker 138 (63%) 32 (55%) 106 (66%)
Alcohol (Units/d) 200 0 (0–2) 1 (0–2) 0 (0–1) .003
Charlson index 219 6.6 (2.1) 6.3 (2.4) 6.6 (1.9) .272
Baseline COPD variables
Clinical phenotype 211 .665
Non-exacerbating 34 (16%) 9 (16%) 25 (16%)
Exacerbating emphysema 61 (29%) 17 (30%) 44 (28%)
Exacerbating chronic bronchitis 80 (38%) 18 (32%) 62 (40%)
Asthma/COPD 36 (17%) 12 (21%) 24 (15%)
Clinical category (GOLD 2017) 204
A 54 (27%) 15 (28%) 39 (26%) .667
B 4 (2%) 0 (0%) 4 (3%)
C 113 (55%) 30 (57%) 83 (55%)
D 33 (16%) 8 (15%) 25 (16%)
Bronchiectasis 209 51 (24%) 12 (22%) 39 (25%) .603
Dyspnea, MRC score 213 .286
0/1 51 (24%) 18 (33%) 33 (21%)
2 124 (58%) 28 (51%) 96 (61%)
3 36 (17%) 9 (16%) 27 (17%)
4 2 (1%) 0 (0%) 2 (1%)
FVC (% provided) 184 61.1 (18.3) 62.9 (19.7) 60.4 (17.9) .426
FEV1 (% provided) 184 48.2 (19.8) 51.9 (21.9) 46.9 (18.9) .133
FEV1/FVC (%) 184 56.2 (12.7) 59.5 (13.2) 55.1 (12.4) .040
Mild/moderate exacerbations 12 months 216 2.1 (1.7) 2.1 (1.4) 2.1 (1.8) .963
Severe exacerbations 12 months 211 0.9 (1.3) 0.6 (1.2) 1 (1.4) .053
COPD exacerbation variables
Anthonisen criteria 219
Dyspnea 215 (98%) 57 (98%) 158 (98%) .946
Expectoration 150 (68%) 41 (71%) 109 (68%) .674
Sputum purulence 61 (28%) 17 (29%) 44 (27%) .773
Arterial blood gas analysis 215 183 (85%) 33 (60%) 150 (94%) <.001
Thorax x-ray performed 217 212 (98%) 53 (93%) 159 (99%) .006
Sputum culture performed 214 6 (3%) 1 (2%) 5 (3%) .591
Blood test performed 219 206 (94%) 47 (81%) 159 (99%) <.001
ECG performed 203 102 (50%) 18 (35%) 84 (55%) .014
Respiratory rate 109 27 (8) 24.8 (8.1) 28.1 (7.7) .066
Heart rate 194 95 (19) 91.1 (19.5) 96.5 (18.6) .082
Systolic blood pressure 192 137 (28) 134.4 (22.6) 137.6 (29.6) .481
Diastolic blood pressure 192 74 (13) 74.6 (11.7) 73.4 (13.4) .554
SpO2 193 92 (6) 94.4 (4.3) 90.5 (5.9) <.001
Exacerbation treatment
Oxygen therapy 162 149 (92%) 33 (83%) 116 (95%) .011
VMNI 87 20 (23%) 0 (0%) 20 (32%) .002
Inhaled therapy 160 160 (96%) 38 (86%) 122 (99%) <.001
Antibiotic 111 70 (63%) 10 (38%) 60 (71%) .003
Corticoids 130 104 (80%) 17 (55%) 87 (88%) <.001
Care management
Time spent in ER 219 6 (4.3–9.7) 6 (4.2–8) 5.9 (4.3–12) .254
Destination after discharge 219 <.001
Home 53 (24%) 53 (91%) 0 (0%)
Pneumology 27 (12%) 0 (0%) 27 (17%)
Internal medicine 97 (44%) 0 (0%) 97 (60%)
Geriatrics 35 (16%) 0 (0%) 35 (22%)
Home hospitalization 2 (1%) 1 (2%) 1 (1%)
Nursing home 3 (1%) 2 (3%) 1 (1%)
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Table 2 presents the same data according to sex. The majority
of women who visited the HED had never consumed tobacco
(63%), and their most frequent clinical phenotype was asthma/
COPD overlap. In addition, women visited their family doctor 3
days earlier after AECOPD onset than men (3.8 vs 6.8 days, P-
value= .048).
Finally, Table 3 shows the patients’ attendance times and triage
levels. The median (P25–P75) time elapsed between arrival to the
HED and the triage was 7 (4–11)minutes, and the time between
triage and the beginning of the medical care was 38 (15–82)
minutes. The waiting times were shorter for more severe patients.
4. Discussion
In this study, which included 219 patients treated for AECOPD in
the HED of the University Hospital Arnau de Vilanova de Lleida,
multiple facets of the health care situation were described in
detail, including: characteristics of the patients; performed
diagnostic tests; applied treatments; main care management
characteristics including response times, destination at discharge,
and need of hospital admission; and ﬁnally, a review of the case at
30 and 90 days to evaluate possible re-admissions and deaths.
This systematic evaluation has allowed us to identify areas for
improvement in the care provided in the HED and will be the
basis for a program providing structured care for AECOPD.
4.1. Clinical aspects
In contrast to other studies,[4] no unnecessary admissions were
detected. As expected, patients who required hospital admission
were older and had more intense hypoxemia, a higher number of
exacerbations in the previous year and worse control of
symptoms at baseline (determined by the modiﬁed Medical
Research Council [mMRC] dyspnea scale) than patients who
were not admitted. The use of noninvasive ventilation was
reserved for severe cases, and all of those patients required
hospitalization. However, a number of potential areas of
improvement were detected, including the low documentation
of relevant variables such as the respiratory rate; the low
utilization of complementary studies such as sputum culture (only
3% of patients); and the under-recording of electrocardiography,
which according toNICE 2010 guidelines should be performed in
all patients to exclude comorbidities.[11] In this sense, appropriate
use of complementary tests according to the individual patient’s
characteristics (risk factors, recurrent exacerbations) and the
exacerbation characteristics (suspicion of complex microorgan-
isms) should be encouraged as it favors accurate decision-
making.
4.2. AECOPD and sex inﬂuences
The volume of female patients evaluated in our HED was similar
to that reported in previous studies.[12] However, some of the
characteristics are worth noting; ﬁrst, there was a high
proportion of women who had never smoked (63%), and
asthma/COPD overlap was the most usual phenotype. Although
no signiﬁcant differences were found between men and women in
terms of systematic care (diagnostic tests, treatments applied,
response times, admission adequacy, re-admissions, and deaths),
a signiﬁcant difference was found in the time elapsed between
discharge and the ﬁrst medical control visit to PC. While men
exhibited a median of 7 days until their ﬁrst visit, in women, this
time was reduced to 4 days. This difference suggests the need for
focused actions directed towards men to reduce the time until the
ﬁrst PC control visit.
4.3. Care management
One of the priorities of our project was to identify areas for
improvement that could reduce patient care times. Patients with
AECOPD exhibited an average of 38minutes between the
assessment by the nursing staff in triage and the beginning of
medical care. To date, no relevant study has evaluated the
attendance times for AECOPD. However, according to the
recommendations of the Catalan Health Institute,[13] the mean
waiting time of patients with a triage degree of II–III should not
exceed 45minutes. One possibility for improving attendance
times might be to incorporate an advanced triage system, in
which nursing staff has the ability to initiate the necessary
diagnostic tests after the usual prioritization of patients but prior
to the ﬁrst contact with HED physicians. This type of
methodology would allow for the efﬁcient use of patients’
waiting time, making the results of key diagnostic tests available
to emergency physicians from the moment that they evaluate the
patient. Advanced triage systems have previously been used for
medical problems such as thoracic and abdominal pain,
n
∗
All (n=219) No admission (n=58) Admission (n=161) P-value†
Deceased 2 (1%) 2 (3%) 0 (0%)
Case revision
Appropriateness of admission 136
Justiﬁed 131 (96%)
Doubtful 5 (4%)
Unjustiﬁed 0 (0%)
Time until next emergency <72hours 209 8 (4%) 4 (7%) 4 (3%) .131
Time until next emergency 209 .528
<30 days 46 (22%) 14 (25%) 32 (21%)
≥30 days 163 (78%) 42 (75%) 121 (79%)
Re-entry at 30 days 213 35 (16%) 9 (16%) 26 (17%) .932
Re-entry at 90 days 213 53 (25%) 11 (20%) 42 (27%) .309
Deceased at 30 days 219 21 (10%) 5 (9%) 16 (10%) .770
Deceased at 90 days 219 30 (14%) 6 (11%) 24 (15%) .401
Days of hospitalization 161 7.2 (4.7) 0 (0) 7.2 (4.7)
Days until ﬁrst medical control 198 6.3 (7.8) 7.3 (8) 6 (7.8) .313
n (%)/median (SD)/median (P25–P75) as appropriate.
∗
Subjects with available information (no missing data).
† Chi-squared test, Student t test, Mann–Whitney U test, as appropriate.
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gynecological symptoms, or fever in pediatric patients, and have
signiﬁcantly reduced patient waiting times.[14]
Additionally, it is vital to reduce the number of hospital
readmissions. The current guidelines for COPD recommend early
follow-up after discharge as an effective measure because, among
other beneﬁts, early follow-up allows for a comprehensive review
and modiﬁcation of the treatment when necessary.[8] In our
study, patients took a median of 6 days to perform the ﬁrst
medical checkup after discharge. Ensuring that the control visit
occurs and reducing the time elapsed until the visit are 2 of the
objectives identiﬁed for the future program of improvement of the
care of AECOPD patients.
Finally, this study identiﬁed deﬁciencies in the collection and
recording of data from patients, both in the computerizedmedical
records (hospital and PC) and in internal HED records, as shown
by the lack of respiratory rate data (recorded in only 50% of
patients). Therefore, it is imperative to establish working codes
and algorithms that allow for satisfactory collection of data from
AECOPD patients to ensure excellence in the management of this
pathology in emergency medicine.
4.4. Strengths and weaknesses
The main strengths of this study are as follows: the extensive
description of the AECOPD care process, including a detailed
description of the patient characteristics, diagnostic tests, applied
treatments, response times, need for hospital admission, and re-
admissions and deaths at 30 and 90 days and the territorial scope
of the studiedHED,which provides care for patients in urban and
rural areas and covers a large territory with a low population
density. The main limitation was the difﬁculty to obtain complete
data from the different sources of information used (electronic
medical records, HED management records, and PC clinical
history). Additionally, no data on passive smoking, occupational
exposures, or exposure to biomass fuels were available. Finally, it
must be acknowledged that this is a single-institution cross-
sectional study.
5. Conclusions
The quality of care provided to AECOPD patients in the HED
was satisfactory and consistent with current clinical guidelines.
However, the following potential areas of improvement were
identiﬁed: realization of sputum cultures when required;
documentation of variables; patient care times; and time to ﬁrst
PC medical follow-up. Therefore, the improvement in quality of
care involves establishing protocols at the HED level to ensure
Table 2
Description of main characteristics and care data of patients with
COPD exacerbation depending on patient sex.
Men
(n=184)
Women
(n=35) P-value
∗
Sociodemographic variables
Age, y 76 (11) 75.2 (11.8) .700
Comorbidity and lifestyle
Tobacco <.001
Never 17 (9%) 22 (63%)
Current smoker 36 (20%) 5 (14%)
Ex-smoker 130 (71%) 8 (23%)
Alcohol (Units/d) 0 (0–2) 0 (0–0) .002
Charlson index 6.6 (2.1) 6.4 (2) .524
Baseline COPD variables
Clinical phenotype <.001
Non-exacerbating 28 (16%) 6 (18%)
Exacerbating emphysema 59 (33%) 2 (6%)
Exacerbating chronic bronchitis 71 (40%) 9 (27%)
Asthma/COPD 20 (11%) 16 (48%)
Clinical category (GOLD 2017) .536
A 44 (26%) 10 (32%)
B 4 (2%) 0 (0%)
C 95 (55%) 18 (58%)
D 30 (17%) 3 (10%)
Bronchiectasis 46 (26%) 5 (15%) .150
Dyspnea, MRC score .611
0/1 44 (25%) 7 (21%)
2 101 (56%) 23 (68%)
3 32 (18%) 4 (12%)
4 2 (1%) 0 (0%)
FVC (% provided) 60.3 (17.7) 64.8 (21.4) .220
FEV1 (% provided) 46.7 (18.9) 56 (22.3) .017
FEV1/FVC (%) 55.3 (12.9) 60.7 (10.6) .034
Mild/moderate exacerbations 12 months 2.1 (1.7) 2.5 (1.9) .228
Severe exacerbations 12 months 0.9 (1.3) 0.6 (1.3) .258
COPD exacerbation variables
Anthonisen criteria
Dyspnea 181 (98%) 34 (97%) .619
Expectoration 127 (69%) 23 (66%) .699
Sputum purulence 52 (28%) 9 (26%) .758
Arterial blood gas analysis 156 (86%) 27 (79%) .308
Thorax x-ray performed 179 (98%) 33 (94%) .142
Sputum culture performed 5 (3%) 1 (3%) .958
Blood test performed 175 (95%) 31 (89%) .134
ECG performed 83 (49%) 19 (58%) .357
Respiratory rate 27.5 (7.7) 26.8 (8.4) .706
Heart rate 95.5 (20) 93.4 (13.4) .562
Systolic blood pressure 136.6 (28.6) 137.4 (24.7) .885
Diastolic blood pressure 73.6 (13.2) 73.9 (12.1) .899
SpO2 91.7 (5.2) 90.9 (7.9) .443
Exacerbation treatment
Oxygen therapy 122 (91%) 27 (96%) .340
VMNI 17 (22%) 3 (33%) .436
Inhaled therapy 131 (95%) 29 (100%) .215
Antibiotics 60 (65%) 10 (53%) .301
Corticoids 84 (79%) 20 (87%) .358
Care management
Time spent in ER 6 (4.3–9.6) 5.6 (4.3–9.9) .983
Destination after discharge .368
Home 45 (24%) 8 (23%)
Pneumology 21 (11%) 6 (17%)
Internal medicine 80 (43%) 17 (49%)
Geriatrics 33 (18%) 2 (6%)
Home hospitalization 1 (1%) 1 (3%)
Nursing home 2 (1%) 1 (3%)
Deceased 2 (1%) 0 (0%)
Men
(n=184)
Women
(n=35) P-value
∗
Case revision
Appropriateness of admission .294
Justiﬁed 137 (90%) 24 (83%)
Doubtful 16 (10%) 5 (17%)
Unjustiﬁed 0 (0%) 0 (0%)
Time until next emergency <72hours 31 (17%) 4 (12%) .423
Time until next emergency 47 (26%) 6 (18%) .317
<30 days 17 (9%) 4 (11%) .687
≥30 days 25 (14%) 5 (15%) .871
Re-entry at 30 days 7.4 (5) 6.3 (2.5) .265
Re-entry at 90 days 6.8 (8.2) 3.8 (4.7) .048
n (%)/median (SD)/median (P25–P75) as appropriate. COPD= chronic obstructive pulmonary disease.
∗
Chi-squared test, Student’s T-test, Mann-Whitney U test, as appropriate.
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that the necessary diagnostic tests are performed, optimize
response times, and ensure the correct documentation of all
information. Likewise, the need to establish more effective
coordination mechanisms between the HED and PC to ensure
appropriate post-discharge follow-up and to prevent future
exacerbations was evident.
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Table 3
Description of elapsed time in emergency room for COPD patients with exacerbation according to the triage score.
Time (min)
Entrance-triage Triage-assistance Entrance-assistance Entrance-discharge
All 7 (4–11) 38 (15–82) 49 (21–98) 346 (245–533)
Triage
2—Emergency 6 (3–9) 31 (9–59) 40 (17–68) 410 (272–696)
3—Urgency 7 (4–12) 37 (16–80) 49 (27–98) 330 (214–464)
4—less urgent 9 (6–14) 79 (50–156) 92 (60–170) 335 (219–448)
5—non-urgent 8 (7–16) 54 (21–111) 64 (26–130) 376 (153–584)
Median (P25–P75).
COPD= chronic obstructive pulmonary disease.
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